, Volume 17, Issue 3, pp 296–297 | Cite as

Evolution of 18FDG pituitary uptake after medical control of acromegaly

  • Jean-Christophe Maiza
  • Cedric Revel


Magnetic Resonance Imaging Adenoma Metabolic Activity Pituitary Adenoma Acromegaly 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Maiza JC, Zunic P, Revel C, Schneebeli S (2012) Acromegaly revealed by 18FDG-PET/CT in a plasmocytoma patient. Pituitary 15:614–615PubMedCrossRefGoogle Scholar
  2. 2.
    Jeong SY, Lee SW, Lee HJ, Kang S, Seo JH, Chun KA, Cho IH, Won KS, Zeon SK, Ahn BC, Lee J (2010) Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging 37:2334–2343PubMedCrossRefGoogle Scholar
  3. 3.
    Taguchi T, Takao T, Iwasaki Y, Oyama K, Yamada S, Inoue M, Terada Y (2010) Diagnostic value of 18F-dihydroxyphenylalanine positron emission tomography for growth hormone-producing pituitary adenoma. Pituitary 13:78–79PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Endocrinology and Metabolic DiseasesCHU Reunion, Groupe Hospitalier Sud-ReunionSaint-PierreFrance
  2. 2.Department of Nuclear MedicineCHU Reunion, Groupe Hospitalier Felix GuyonSaint-DenisFrance

Personalised recommendations